Anastasilakis, Athanasios D <br/><br/>
Increased osteoclastogenesis in patients with vertebral fractures following discontinuation of denosumab treatment.  [electronic resource] 

 -  European journal of endocrinology  Jun 2017 
 - 677-683 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1479-683X 
<br/><br/><label>Standard No.: </label>10.1530/EJE-16-1027  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Bone Density Conservation Agents--therapeutic use<br/>Bone Remodeling--genetics<br/>Case-Control Studies<br/>Cathepsin K--genetics<br/>Collagen Type I--metabolism<br/>Denosumab--therapeutic use<br/>Deprescriptions<br/>Down-Regulation<br/>Female<br/>Gene Expression Regulation<br/>Humans<br/>MicroRNAs--metabolism<br/>Middle Aged<br/>Osteogenesis--genetics<br/>Osteoporosis, Postmenopausal--drug therapy<br/>Osteoporotic Fractures--genetics<br/>Peptide Fragments--metabolism<br/>Peptides--metabolism<br/>Procollagen--metabolism<br/>RNA, Messenger--metabolism<br/>Receptor Activator of Nuclear Factor-kappa B--genetics<br/>Spinal Fractures--genetics